Hemodynamic effects of nicorandil, isosorbide dinitrate, and dihydralazine in healthy volunteers
- PMID: 2418296
- DOI: 10.1097/00005344-198511000-00015
Hemodynamic effects of nicorandil, isosorbide dinitrate, and dihydralazine in healthy volunteers
Abstract
In this randomized, double-blind, crossover, single-dose study with 12 healthy subjects, we determined the hemodynamic changes and their time kinetics after administration of the mononitrate nicorandil (60 mg s.l.) and compared these effects with changes after administration of isosorbide dinitrate (ISDN; 20 mg s.l.), dihydralazine (10 mg i.v.), and placebo. Mechanocardiography, electrical impedance cardiography, and M-mode echocardiography measured drug effects. Dihydralazine increased heart rate, systolic pressure, and ventricular ejection time, and it decreased peripheral resistance, diastolic pressure, preejection period, end-systolic diameter and wall stress; these changes indicate an intense, pure afterload reduction. ISDN decreased systolic pressure, peripheral resistance, end-diastolic and systolic diameters and wall stress, shortened the ejection time, and prolonged the preejection period. The responses suggest ISDN causes a notable preload reduction accompanied by some afterload reduction. Nicorandil's effects were similar to those of ISDN in that the reductions in preload were equal, although the afterload reduction was more intense. Nicorandil's effects reached significance within 10 min, reached a maximum by 60 min, and had not vanished at 4 h. A drug with this profile and time kinetics should be tested further in situations requiring pre- and afterload reductions.
Similar articles
-
Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man.Eur J Clin Pharmacol. 1984;26(6):681-5. doi: 10.1007/BF00541925. Eur J Clin Pharmacol. 1984. PMID: 6237916 Clinical Trial.
-
Dynamic responses to intravenous urapidil and dihydralazine in normal subjects.Clin Pharmacol Ther. 1985 Jan;37(1):48-54. doi: 10.1038/clpt.1985.10. Clin Pharmacol Ther. 1985. PMID: 3880685 Clinical Trial.
-
Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.J Cardiovasc Pharmacol. 1995;26 Suppl 4:S80-90. J Cardiovasc Pharmacol. 1995. PMID: 8839231 Clinical Trial.
-
Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.Eur Heart J. 1993 Jul;14 Suppl B:16-21. doi: 10.1093/eurheartj/14.suppl_b.16. Eur Heart J. 1993. PMID: 8370366 Review.
-
Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.J Cardiovasc Pharmacol. 1992;20 Suppl 3:S93-102. J Cardiovasc Pharmacol. 1992. PMID: 1282184 Review.
Cited by
-
Differential effects of the novel NO-donating drug pirsidomine and isosorbide dinitrate on the venous vascular bed.Eur J Clin Pharmacol. 1994;46(4):295-9. doi: 10.1007/BF00194394. Eur J Clin Pharmacol. 1994. PMID: 7957511 Clinical Trial.
-
Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers.Cardiovasc Drugs Ther. 1995 Apr;9(2):331-7. doi: 10.1007/BF00878678. Cardiovasc Drugs Ther. 1995. PMID: 7662600 Clinical Trial.
-
A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.Cardiovasc Drugs Ther. 1993 Feb;7(1):119-23. doi: 10.1007/BF00878320. Cardiovasc Drugs Ther. 1993. PMID: 8485067 Clinical Trial.
-
Systolic time intervals in clinical pharmacology.Eur J Clin Pharmacol. 1993;44(5):415-21. doi: 10.1007/BF00315536. Eur J Clin Pharmacol. 1993. PMID: 8359176 Review. No abstract available.
-
Electrophysiologic effects of potassium channel openers.Cardiovasc Drugs Ther. 1995 Mar;9 Suppl 2:195-202. doi: 10.1007/BF00878466. Cardiovasc Drugs Ther. 1995. PMID: 7647023 Review.